DHGWA
CLB icon

Dixon Hughes Goodman Wealth Advisors’s Core Laboratories CLB Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$6K Hold
193
– – ﹤0.01% 570
2021
Q4 		$4K Buy
+193
New +$5.03K ﹤0.01% 576

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
CPH
C Partners Holding Zurich, Switzerland $317M AUM 4.76% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's CLB Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors held its Core Laboratories (CLB) position steady in Q1 2022 at 193 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #570.

Dixon Hughes Goodman Wealth Advisors first reported a position in CLB in Q4 2021 and has held it in 2 quarters since. 196 funds tracked by Wall St. Rank hold CLB as of Q1 2022.

  • Dixon Hughes Goodman Wealth Advisors held 193 shares of Core Laboratories worth $6K as of Q1 2022.
  • Dixon Hughes Goodman Wealth Advisors left its Core Laboratories share count unchanged in Q1 2022.
  • Core Laboratories made up ﹤0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #570 holding.
  • Dixon Hughes Goodman Wealth Advisors first reported a position in Core Laboratories in Q4 2021 and has held it in 2 quarters since.
  • 196 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.